What is changing with the new ISO 10993-1 version 2025
In this episode of the Medical Device Made Easy Podcast, Monir El Azzouzi talks with Marina Deineka (Intrinsic Medical Group) ...
What Is Changing With The New Iso 10993 1 Version 2025 PuuChHvzZ6Q
In this episode of the Medical Device Made Easy Podcast, Monir El Azzouzi talks with Marina Deineka (Intrinsic Medical Group) ... The medical device industry...
The New ISO 10993-1 2025 - Big changes to implement
The medical device industry operates at the confluence of innovation, patient safety, and rigorous regulatory standards.
ISO 10993-1:2025 Explained: What Medical Device Teams Need to Change in Biological Evaluation
This video is for medical device, IVD, pharma, and combination product professionals who need to understand what
ISO 10993-1:2025: What Risk-Based Biocompatibility Means for MedTech
In this episode, Etienne Nichols sits down with Thor Rollins, a leader at Nelson Labs and the convener of the committee revising ...
What Manufacturers Need to Know about the Updated ISO 10993-1 and New ISO 21726
The approach expected by regulators for evaluation of medical device biocompatibility has been rapidly
Big Changes to ISO 10993-1, what is happening to the main biocompatibility standard now?
In 2018, TC194, the
2-part Webinar: Navigating the ISO 10993-1:2025 & Challenges Encountered During ISO 10993-18 Testing
Part I Navigating the
What does risk-based biocompatibility under the new ISO 10993-1 really look like?
The era of the "checklist" approach to biocompatibility is officially over. With the publication of
Big Changes to ISO 10993-1, What is Happening to the Main Biocompatibility Standard Now?
In 2018, TC194, the
Updates Coming to ISO 10993 1
Significant updates are coming to
ISO 10993 1 Key update on the new revision of this critical standard
This presentation will delve into the
Understanding the Updates to ISO 10993-1: Biological Evaluation of Medical Devices
Gain critical insights into the
ISO 10993-1 Biological Evaluation Plan (BEP) Webinar | Expert Insights from TÜV Rheinland & AIMED
Biological Evaluation Plan (BEP) under